Key facts
- This page summarizes Joseph Ciaffoni's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2024, 16:13.
Joseph Ciaffoni - 12 Feb 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- COLL
- Reported as of
- 12 Feb 2024
- Net transaction value
- -$4,342,818
- SEC form
- 4
- Accepted by SEC
- 14 Feb 2024, 16:13:23 UTC
- Prior SEC filing
- 22 Dec 2023
- Next SEC filing
- 07 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Joseph Ciaffoni filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 14 Feb 2024.
Change
- Previous filing in this sequence was filed on 22 Dec 2023.
- Current net transaction value: -$4,342,818.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
COLL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +119,000
- Change %
- +43%
- Price
- $0.000000
- Shares after
- 394,000
- Date
- 12 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
COLL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +179,734
- Change %
- +46%
- Price
- $0.000000
- Shares after
- 573,734
- Date
- 12 Feb 2024
- Ownership
- Direct
- Footnotes
- F2
COLL
transaction
Common Stock
Tax liability
- Transaction value
- $1,598,896
- Shares
- -47,445
- Change %
- -8.3%
- Price
- $33.70
- Shares after
- 526,289
- Date
- 12 Feb 2024
- Ownership
- Direct
- Footnotes
- F3
COLL
transaction
Common Stock
Tax liability
- Transaction value
- $2,743,921
- Shares
- -81,422
- Change %
- -15%
- Price
- $33.70
- Shares after
- 444,867
- Date
- 12 Feb 2024
- Ownership
- Direct
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
Footnote F2
Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 179,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
Footnote F3
Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
Footnote F4
Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.